Andrey I. Nikiforov
Research Subjects
Andrey I. Nikiforov has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Marisa O. Rihner
Toxicology Regulatory Services, Charlottesville, VA, USA
6 shared publications- Marisa O. Rihner
Toxicology Regulatory Services, 2365 Hunters Way, Charlottesville, VA 22911, USA
6 shared publications - Christine M. Crincoli
Cargill, Incorporated, 15407 McGinty Rd West, Wayzata, MN 55391, USA
5 shared publications Jens Bitzer
IMD Natural Solutions GmbH, Dortmund, Germany
5 shared publicationsThomas Henkel
IMD Natural Solutions GmbH, Dortmund, Germany
5 shared publications- Witty A. Brathwaite
Cargill Limited, 300-240 Graham Avenue Winnipeg, MB, R3C 4C5, Canada
5 shared publications
Latest Publications
- Open Access
Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements
With the growing popularity of probiotics in dietary supplements, foods, and beverages, it is important to substantiate not only the health benefits and efficacy of unique strains but also safety. In the interest of consumer safety and product transparency, strain identification should include whole-genome sequencing and safety assessment should include genotypic and phenotypic studies. Bacillus subtilis MB40, a unique strain marketed for use in dietary supplements, and food and beverage, was assessed for safety and tolerability across in silico, in vitro, and in vivo studies. MB40 was assessed for the absence of undesirable genetic elements encoding toxins and mobile antibiotic resistance. Tolerability was assessed in both rats and healthy human volunteers. In silico and in vitro testing confirmed the absence of enterotoxin and mobile antibiotic resistance genes of safety concern to humans. In rats, the no-observed-adverse-effect level (NOAEL) for MB40 after repeated oral administration for 14 days was determined to be 2000 mg/kg bw/day (equivalent to 3.7 × 1011 CFU/kg bw/day). In a 28 day human tolerability trial, 10 × 109 CFU/day of MB40 was well tolerated. Based on genome sequencing, strain characterization, screening for undesirable attributes and evidence of safety by appropriately designed safety evaluation studies in rats and humans, Bacillus subtilis MB40 does not pose any human health concerns under the conditions tested.
Open AccessSafety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements
With the growing popularity of probiotics in dietary supplements, foods, and beverages, it is important to substantiate not only the health benefits and efficacy of unique strains but also safety. In the interest of consumer safety and product transparency, strain identification should include whole-genome sequencing and safety assessment should include genotypic and phenotypic studies. Bacillus subtilis MB40, a unique strain marketed for use in dietary supplements, and food and beverage, was assessed for safety and tolerability across in silico, in vitro, and in vivo studies. MB40 was assessed for the absence of undesirable genetic elements encoding toxins and mobile antibiotic resistance. Tolerability was assessed in both rats and healthy human volunteers. In silico and in vitro testing confirmed the absence of enterotoxin and mobile antibiotic resistance genes of safety concern to humans. In rats, the no-observed-adverse-effect level (NOAEL) for MB40 after repeated oral administration for 14 days was determined to be 2000 mg/kg bw/day (equivalent to 3.7 × 1011 CFU/kg bw/day). In a 28 day human tolerability trial, 10 × 109 CFU/day of MB40 was well tolerated. Based on genome sequencing, strain characterization, screening for undesirable attributes and evidence of safety by appropriately designed safety evaluation studies in rats and humans, Bacillus subtilis MB40 does not pose any human health concerns under the conditions tested.
- 1 February 2020
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (2) , 396-397
“Bug Off! Severe toxicity following inhalation exposure to N,N-diethyl-meta-toluamide DEET” Tavares et al., 2019; AJEM
- 1 February 2020
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 38 (2) , 396-397
“Bug Off! Severe toxicity following inhalation exposure to N,N-diethyl-meta-toluamide DEET” Tavares et al., 2019; AJEM
- 1 January 2019
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 123, 162-168
Genetic toxicity studies of glycolipids from Dacryopinax spathularia
- 1 January 2019
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 123, 162-168
Genetic toxicity studies of glycolipids from Dacryopinax spathularia
- 1 October 2018
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 120, 430-438
Developmental and reproduction toxicity studies of glycolipids from Dacryopinax spathularia
- 1 October 2018
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 120, 430-438
Developmental and reproduction toxicity studies of glycolipids from Dacryopinax spathularia
- 1 November 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 109, 552-568
Pharmacokinetics, excretion balance, and tissue distribution of [14C]-labeled glycolipids and long chain fatty acids from Dacryopinax spathularia in rats
- 1 November 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 109, 552-568
Pharmacokinetics, excretion balance, and tissue distribution of [14C]-labeled glycolipids and long chain fatty acids from Dacryopinax spathularia in rats
- 1 November 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 109, 544-551
A 90-day oral toxicity study of glycolipids from Dacryopinax spathularia in Beagle dogs
- 1 November 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 109, 544-551
A 90-day oral toxicity study of glycolipids from Dacryopinax spathularia in Beagle dogs
- 1 November 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 109, 569-584
A 90-day oral toxicity study of glycolipids from Dacryopinax spathularia in CD® rats
- 1 November 2017
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 109, 569-584
A 90-day oral toxicity study of glycolipids from Dacryopinax spathularia in CD® rats
- 1 May 2016
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 91, 202-216
A combined dietary chronic toxicity and two-year carcinogenicity study of (2R,4R)-monatin salt in Sprague–Dawley rats
- 1 May 2016
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 91, 202-216
A combined dietary chronic toxicity and two-year carcinogenicity study of (2R,4R)-monatin salt in Sprague–Dawley rats
- 1 May 2016
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 91, 191-201
A two-year dietary carcinogenicity study of (2R,4R)-monatin salt in mice
- 1 May 2016
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 91, 191-201
A two-year dietary carcinogenicity study of (2R,4R)-monatin salt in mice